Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

Scientists uncover the exact mode of action of five antibiotic drugs

Weizmann Institute Of Science : 25 October, 2001  (Company News)
Researchers from the Weizmann Institute of Science and Germany's Max-Planck Society have discovered how five antibiotic drugs function by binding to the bacterial ribosome, the cell's 'protein factory', and shutting off all protein production. Proteins are the cell's primary component and the basis of all enzymatic reactions. Blocking their production kills the bacterium.
Researchers from the Weizmann Institute of Science and Germany's Max-Planck Society have discovered how five antibiotic drugs function by binding to the bacterial ribosome, the cell's 'protein factory', and shutting off all protein production. Proteins are the cell's primary component and the basis of all enzymatic reactions. Blocking their production kills the bacterium.

The research team headed by Prof. Ada Yonath of the Weizmann Institute's Structural Biology Department and the Max-Planck Research Units for Ribosomal Structure in Hamburg and Berlin uncovered the exact mode of action of these drugs. Prof. Yonath recently revealed the complex structure of the ribosome, culminating 20 years of scientific research in a study described by the prestigious journal Science, as one of the most important scientific discoveries of the year 2000. The goal of elucidating the structure of the ribosome, a notoriously unstable, giant nucleoprotein complex, had challenged scientists for years.

Using their extensive understanding of ribosomal structure, Prof. Ada Yonath, Dr. Anat Bashan, and Ph.D. student Raz Zarivach, decided to examine how different antibiotics bind to the ribosome and 'shut off' its protein production. To do so they created crystals capturing individual complexes formed between the bacterial ribosome and each of five different antibiotic drugs.

To examine these microscopic structures the scientists bombarded the crystals with high intensity X-ray beams, analyzed how the rays diffract, and then worked backward to decipher the crystal's exact structure, a technology known as X-ray crystallography. Using this method, the researchers were able, for the first time, to view how the antibiotic drugs bind to a specific site of action on the ribosome, shutting off its machinery. These findings are reported today in Nature.

A better understanding of the mode of action of antibiotic drugs may improve the treatment strategies of existing drugs, and lead to rational drug design of antibiotics designed to better target bacterial agents at the ribosomal level.

The Max-Planck scientists collaborating in this study are Francois Franceschi, Joerg Harms, Ante Tocilj, Renate Albrecht, and Frank Schluenzen.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 NewMaterials.com
Netgains Logo